Plaunotol is primarily used in the treatment of gastric ulcers and other gastrointestinal disorders. It works by promoting the healing of gastric mucosal lesions and enhancing the protective mechanisms of the stomach lining. The compound is known to stimulate the production of prostaglandins, which play a crucial role in maintaining the integrity of the gastric mucosa. Additionally, Plaunotol has been found to inhibit the growth of Helicobacter pylori, a bacterium associated with peptic ulcers and gastritis. Its application is particularly beneficial for patients who require long-term management of gastric conditions, offering a therapeutic option that supports mucosal repair and reduces the risk of ulcer recurrence.